CTOs on the Move

Attralus

www.attralus.com

 
Amyloid diseases are a diverse group of disorders, characterized by the deposition of amyloid protein fibrils in vital organs and tissues. There are approximately 30 different types of amyloidosis, each resulting from the misfolding and aggregation of a specific protein, and they are all severely debilitating, progressive, and often fatal.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.attralus.com
  • ‍329 Oyster Point Blvd Third Floor
    South San Francisco, BC USA 94080
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Attralus raised $25M on 09/14/2020

Similar Companies

M Silicon Biosystems

Solutions for isolation, recovery, and analysis of intact, individual rare cells. Single "cell sorter"

Geneos Therapeutics

Geneos is developing personalized immunotherapies against tumor specific neoantigens which arise from gene mutations in cancerous cells.

BioElectron Technology Corporation

BioElectron is a platform biotechnology company, with expertise in the electron transfer (redox) chemical reactions that underpin oxidative stress and inflammation in all biological systems.

Gemin

Gemin

bioMASON

We build with carbon the same way nature does. Our biocement® materials are healthier for us and the Planet.